1Department of Dermatology, Royal Free Hospital, Hampstead, London, UK.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
A patient developed blue-grey skin pigmentation from long-term, low-dose Stelazine treatment. This rare side effect, oculocutaneous melanosis, affects sun-exposed areas due to phenothiazine use.
Area of Science:
Background:
Observation:
Findings:
Implications: